ATE476449T1 - Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen - Google Patents
Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellenInfo
- Publication number
- ATE476449T1 ATE476449T1 AT05847825T AT05847825T ATE476449T1 AT E476449 T1 ATE476449 T1 AT E476449T1 AT 05847825 T AT05847825 T AT 05847825T AT 05847825 T AT05847825 T AT 05847825T AT E476449 T1 ATE476449 T1 AT E476449T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- endosial
- monoclonal antibodies
- inpositive
- isolate
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/515—Angiogenesic factors; Angiogenin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63306004P | 2004-12-03 | 2004-12-03 | |
| PCT/US2005/043749 WO2006060719A2 (en) | 2004-12-03 | 2005-12-02 | Use of endosialin binding proteins to isolate endosialin positive cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE476449T1 true ATE476449T1 (de) | 2010-08-15 |
Family
ID=36565803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05847825T ATE476449T1 (de) | 2004-12-03 | 2005-12-02 | Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060121541A1 (de) |
| EP (1) | EP1819736B1 (de) |
| AT (1) | ATE476449T1 (de) |
| AU (1) | AU2005311660B2 (de) |
| CA (1) | CA2590583A1 (de) |
| DE (1) | DE602005022757D1 (de) |
| WO (1) | WO2006060719A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006241235B2 (en) | 2005-04-22 | 2012-04-05 | Eisai, Inc. | Antibodies with immune effector activity and that internalize in endosialin-positive cells |
| RS55447B1 (sr) | 2007-04-05 | 2017-04-28 | Morphotek Inc | Metode za inhibiranje vezivanja endosijalina za ligande |
| US20100260769A1 (en) * | 2009-04-09 | 2010-10-14 | Morphotek, Inc. | Endosialin binding molecules |
| US20130305396A1 (en) * | 2010-09-29 | 2013-11-14 | Luigi Grasso | Engineered human endosialin-expressing rodents |
| DE102017125150B4 (de) | 2017-10-26 | 2019-10-10 | Epiontis Gmbh | Endosialin (CD248) als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere naïver CD8+ T-Zellen |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US121541A (en) * | 1871-12-05 | Improvement in folding plant-stands | ||
| US239911A (en) * | 1881-04-05 | Parasol | ||
| US248034A (en) * | 1881-10-11 | gibbs | ||
| US20271A (en) * | 1858-05-18 | Improvement in harvesters | ||
| US5789650A (en) * | 1990-08-29 | 1998-08-04 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5342757A (en) * | 1992-11-13 | 1994-08-30 | Ludwig Institute For Cancer Research | Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
| AU6102494A (en) * | 1993-02-05 | 1994-08-29 | Epigen, Inc. | Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| EP0746613B1 (de) * | 1994-03-08 | 2006-05-24 | Memorial Sloan-Kettering Cancer Center | Rekombinante humanisierte antikörper gegen fb5 |
| DE19541844C1 (de) * | 1995-11-09 | 1997-07-24 | Gsf Forschungszentrum Umwelt | Verfahren zur Herstellung von menschlichen Antikörpern und deren Verwendung |
| US6146894A (en) * | 1998-04-14 | 2000-11-14 | The Johns Hopkins University | Method for generating hypermutable organisms |
| CN1832965B (zh) * | 2003-03-04 | 2011-03-02 | 麒麟麦酒株式会社 | 内皮细胞特异性抗体及其用途 |
| US6905082B1 (en) * | 2003-12-05 | 2005-06-14 | Sheng Li Wu | Sprayer device having buffering structure |
| WO2005086713A2 (en) * | 2004-03-04 | 2005-09-22 | Kirin Brewery Co., Ltd. | Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis |
| AU2006241235B2 (en) * | 2005-04-22 | 2012-04-05 | Eisai, Inc. | Antibodies with immune effector activity and that internalize in endosialin-positive cells |
-
2005
- 2005-12-02 AT AT05847825T patent/ATE476449T1/de not_active IP Right Cessation
- 2005-12-02 CA CA002590583A patent/CA2590583A1/en not_active Abandoned
- 2005-12-02 US US11/292,634 patent/US20060121541A1/en not_active Abandoned
- 2005-12-02 WO PCT/US2005/043749 patent/WO2006060719A2/en not_active Ceased
- 2005-12-02 DE DE602005022757T patent/DE602005022757D1/de not_active Expired - Lifetime
- 2005-12-02 AU AU2005311660A patent/AU2005311660B2/en not_active Ceased
- 2005-12-02 EP EP05847825A patent/EP1819736B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1819736A2 (de) | 2007-08-22 |
| DE602005022757D1 (de) | 2010-09-16 |
| AU2005311660B2 (en) | 2011-07-07 |
| EP1819736B1 (de) | 2010-08-04 |
| WO2006060719A2 (en) | 2006-06-08 |
| AU2005311660A1 (en) | 2006-06-08 |
| CA2590583A1 (en) | 2006-06-08 |
| US20060121541A1 (en) | 2006-06-08 |
| WO2006060719A3 (en) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1117702T1 (el) | Πρωτεϊνες δεσμευομενες με αντιγονο ικανες να δεσμευονται με θυμικη στρωματικη λεμφοποιητινη | |
| TR201910213T4 (tr) | Disülfürle stabilize edilmiş çok değerlikli antikorlar. | |
| BRPI0507433B8 (pt) | anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit | |
| MX2018013008A (es) | Anticuerpos st-2 humanos solubles y ensayos. | |
| MX2024003355A (es) | Anticuerpos anti-cd3. | |
| UA99701C2 (ru) | Человеческое моноклональное антитело, которое специфически связывается с лигандом-1 запрограммированной гибели клеток (pd-l1) | |
| EP2352523A4 (de) | Verbesserte anti-cd19-antikörper | |
| MX2013006428A (es) | Proteinas de union a tnf-alfa. | |
| MX2010002269A (es) | Composiciones y metodos que comprenden proteinas de union para adalimumab. | |
| EA201591407A1 (ru) | Антитела, содержащие химерные константные домены | |
| MX338953B (es) | Metodos para la generacion de anticuerpos multiespecificos y multivalentes. | |
| EA201490825A8 (ru) | Tdp-43-специфически связывающие молекулы | |
| BRPI0613382A8 (pt) | anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor | |
| EA201890928A1 (ru) | Антигенсвязывающие белки, которые активируют лептиновый рецептор | |
| EP2534257A4 (de) | Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden | |
| EA201101516A1 (ru) | Антитела, специфические для кадгерина-17 | |
| EA200970477A1 (ru) | Человеческие моноклональные антитела к btla и способы применения | |
| NO20084650L (no) | Modifiserte humaniserte anti-interleukin-18 antistoffer | |
| MX2022006709A (es) | Anticuerpos antiidiotípicos para dominios de unión dirigidos a bcma y métodos y composiciones relacionadas. | |
| RU2014103784A (ru) | Антитело, блокирующее agr2, и его применение | |
| EA201101242A1 (ru) | Полностью человеческие антитела, специфические для cadm1 | |
| MX352117B (es) | Anticuerpo anti-idiotipo dirigido contra un anticuerpo dirigido contra el peptido beta amiloideo. | |
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| EA200702361A1 (ru) | АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ | |
| DE602005022757D1 (de) | Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |